ArticleMolecular cancer therapeutics2021

Belantamab Mafodotin (GSK2857916) Drives Immunogenic Cell Death and Immune-mediated Antitumor Responses

Rocio Montes de Oca et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.